Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ZIMV ZimVie
9.810+0.690+7.57%
Close
01/31 16:00 ET
9.8100.0000.00%
Post Mkt Price 01/31 16:08 ET
High
9.970
Open
9.160
Turnover
4.42M
Low
9.160
Pre Close
9.120
Volume
452.73K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
ZimVie's Mobi-C Replaces More Than 200,000 Cervical Discs
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced With Mobi-C
6,894 Shares in ZimVie Inc. (NASDAQ:ZIMV) Purchased by Oregon Public Employees Retirement Fund
Oregon Public Employees Retirement Fund bought a new stake in ZimVie Inc. (NASDAQ:ZIMV – Get Rating) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Comm
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
A member of Congress sold out of his positions in several stocks at the end of 2022. The move came as he finished his term serving the state of Texas and announced his retirement.
ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference
WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 4
ZimVie (NASDAQ:ZIMV) Coverage Initiated by Analysts at Barclays
Barclays began coverage on shares of ZimVie (NASDAQ:ZIMV – Get Rating) in a research report report published on Wednesday, The Fly reports. The brokerage issued an underweight rating and a $9.00 targ
ZimVie (NASDAQ:ZIMV) Now Covered by Analysts at Barclays
Barclays assumed coverage on shares of ZimVie (NASDAQ:ZIMV – Get Rating) in a report released on Wednesday morning, The Fly reports. The brokerage issued an underweight rating and a $9.00 target pric
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
UpgradesFor PagSeguro Digital Ltd (NYSE:PAGS), New Street Research upgraded the previous rating of Neutral to Buy. In the third quarter, PagSeguro Digital showed an EPS of $0.24, compared to $0.24 fro
ZimVie Price Target Announced at $9.00/Share by Barclays
ZimVie Price Target Announced at $9.00/Share by Barclays
Company Overview
More
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Westminster, CO.
CEO： Mr. Vafa Jamali
Market： NASDAQ
Listing Date： 02/16/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet